Please use this identifier to cite or link to this item:
|Web of Science®
|Molecular pathology of expanded polyalanine tract mutations in the Aristaless-related homeobox gene
|Genomics, 2007; 90(1):59-71
|Academic Press Inc Elsevier Science
|Cheryl Shoubridge, Desiree Cloosterman, Emma Parkinson–Lawerence, Douglas Brooks and Jozef Gécz
|The Aristaless-related homeobox gene (ARX) is one of the major genes causing X-linked mental retardation. We have been interested in the pathogenic mechanism of expanded polyalanine tract mutations in ARX. We showed that the c.304ins(GCG)7 mutation causing an increase from 16 to 23 alanines increased the propensity of ARX protein aggregation and a shift from nuclear to cytoplasmic localization. We proposed that mislocalization of ARX via cytoplasmic aggregation and subsequent degradation leads to a partial loss of function, contributing to the pathogenesis. We identified importin 13 (IPO13), a mediator of nuclear import for a variety of proteins, as a novel ARX interacting protein. We predicted that the transport of ARX by IPO13 from the cytoplasm to the nucleus might be disrupted by expanded polyalanine tract mutations, but our data showed that in both yeast and mammalian cells these mutant ARX proteins were still able to interact with IPO13. We established the nuclear localization regions of the ARX homeodomain that were required for the interaction with IPO13 and correct localization of the full-length ARX transcription factor to the nucleus.
Cell Line, Tumor
Mental Retardation, X-Linked
Amino Acid Sequence
Active Transport, Cell Nucleus
Molecular Sequence Data
|Crown copyright © 2007 Published by Elsevier Inc.
|Appears in Collections:
|Aurora harvest 6
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.